Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, Clover Health Investments Corp (NASDAQ: CLOV) closed at $4.14 down -4.17% from its previous closing price of $4.32. In other words, the price has decreased by -$4.17 from its previous closing price. On the day, 4.74 million shares were traded.
Ratios:
For a deeper understanding of Clover Health Investments Corp’s stock, let’s take a closer look at its various ratios. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Craig Hallum on December 17, 2024, initiated with a Buy rating and assigned the stock a target price of $6.
On October 07, 2024, UBS started tracking the stock assigning a Neutral rating and target price of $4.
Cowen Upgraded its Underperform to Market Perform on February 02, 2022, whereas the target price for the stock was revised from $7 to $3.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 09 ’24 when Garipalli Vivek bought 531,700 shares for $1.88 per share. The transaction valued at 999,596 led to the insider holds 1,409,267 shares of the business.
Garipalli Vivek bought 877,567 shares of CLOV for $1,000,426 on Jun 17 ’24. The Director now owns 877,567 shares after completing the transaction at $1.14 per share. On May 16 ’24, another insider, Loengard Anna U, who serves as the Director of the company, bought 17,085 shares for $0.96 each. As a result, the insider paid 16,372 and bolstered with 15,600 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.35 while its Price-to-Book (P/B) ratio in mrq is 5.85.
Stock Price History:
Over the past 52 weeks, CLOV has reached a high of $4.87, while it has fallen to a 52-week low of $0.61. The 50-Day Moving Average of the stock is 4.29%, while the 200-Day Moving Average is calculated to be 44.85%.
Shares Statistics:
A total of 394.44M shares are outstanding, with a floating share count of 376.53M. Insiders hold about 24.86% of the company’s shares, while institutions hold 18.57% stake in the company.
